Evidence map›Paper›PMID 34216514›Full record

ArticleJournal of clinical laboratory analysis2021

miR-92a promotes cervical cancer cell proliferation, invasion, and migration by directly targeting PIK3R1.

Yijun Wang, Aner Chen, Chenyang Zheng, Lingjun Zhao

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical laboratory analysis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yijun WangDepartment of Gynecology, Ningbo Women and Children's Hospital, Ningbo, China.ORCID https://orcid.org/0000-0001-8921-8302
Aner ChenDepartment of Gynecology, Ningbo Women and Children's Hospital, Ningbo, China.
Chenyang ZhengDepartment of Gynecology, Ningbo Women and Children's Hospital, Ningbo, China.
Lingjun ZhaoDepartment of Gynecology, Ningbo Women and Children's Hospital, Ningbo, China.
Ningbo No.6 Hospital · CN

Funding

Public Welfare Science and Technology Plan Project of Ningbo, Major social development projects of Ningbo 2013C51015
6 · The paper itself

Abstract

objectiveTo clarify the role of miR-92a in regulating the malignant progression of cervical cancer and its specific molecular mechanism.

methodsqRT-PCR was used to detect the differential expression of miR-92a in cervical cancer and adjacent tissues. The effects of overexpression of miR-92a on the proliferation, migration, and invasion of HeLa and SiHa cells were tested. Luciferase assays and rescue experiments were used to investigate the regulatory mechanism of miR-92a on its downstream gene PIK3R1 and their interaction in the progression of cervical cancer.

resultsmiR-92a was significantly up-regulated in cervical cancer tissues. Overexpression of miR-92a significantly increased the ability of cervical cancer cells to proliferate, migrate, and invade. PIK3R1 was identified as a downstream gene of miR-92a. In cervical cancer tissues, PIK3R1 was found to be down-regulated and negatively correlated with the level of miR-92a. Overexpression of PIK3R1 reversed the promotional effect of overexpressed miR-92a on the proliferation, migration, and invasion of cervical cancer.

conclusionmiR-92a is up-regulated in cervical cancer tissues. miR-92a promotes the malignant development of cervical cancer by negatively regulating PIK3R1.

Indexed as

Cell Line, TumorCell MovementCell ProliferationClass Ia Phosphatidylinositol 3-KinaseFemaleGene Expression Regulation, NeoplasticHumansMicroRNAsUp-RegulationUterine Cervical NeoplasmsClass Ia Phosphatidylinositol 3-KinaseMicroRNAsMIRN92 microRNA, humanPIK3R1 protein, humancervical cancermiR-92aPIK3R1

Identifiers

PMID34216514
PMCPMC8373326
OpenAlexW3177522796

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.